Quantifying circulating cell-free DNA in humans.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 03 2019
Historique:
received: 06 09 2018
accepted: 09 01 2019
entrez: 28 3 2019
pubmed: 28 3 2019
medline: 2 10 2020
Statut: epublish

Résumé

To our knowledge, this is the first comprehensive study on the influence of several pre-analytical and demographic parameters that could be a source of variability in the quantification of nuclear and mitochondrial circulating DNA (NcirDNA and McirDNA). We report data from a total of 222 subjects, 104 healthy individuals and 118 metastatic colorectal cancer (mCRC) patients. Approximately 50,000 and 3,000-fold more mitochondrial than nuclear genome copies were found in the plasma of healthy individuals and mCRC patients, respectively. In healthy individuals, NcirDNA concentration was statistically influenced by age (p = 0.009) and gender (p = 0.048). Multivariate analysis with logistic regression specified that age over 47 years-old was predictive to have higher NcirDNA concentration (OR = 2.41; p = 0.033). McirDNA concentration was independent of age and gender in healthy individuals. In mCRC patients, NcirDNA and McirDNA levels were independent of age, gender, delay between food intake and blood collection, and plasma aspect, either with univariate or multivariate analysis. Nonetheless, ad hoc study suggested that menopause and blood collection time might have tendency to influence cirDNA quantification. In addition, high significant statistical differences were found between mCRC patients and healthy individuals for NcirDNA (p < 0.0001), McirDNA (p < 0.0001) and McirDNA/NcirDNA ratio (p < 0.0001). NcirDNA and McirDNA levels do not vary in the same way with regards to cancer vs healthy status, pre-analytical and demographic factors.

Identifiants

pubmed: 30914716
doi: 10.1038/s41598-019-41593-4
pii: 10.1038/s41598-019-41593-4
pmc: PMC6435718
doi:

Substances chimiques

Circulating Tumor DNA 0
DNA, Mitochondrial 0

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5220

Références

Eur J Immunol. 2014 May;44(5):1552-62
pubmed: 24470107
Lung Cancer. 2010 May;68(2):283-7
pubmed: 19632736
Clin Cancer Res. 2016 Jun 15;22(12):3067-77
pubmed: 26847055
Clin Chem. 2000 Dec;46(12):1903-6
pubmed: 11106320
Am J Hum Genet. 1998 Apr;62(4):768-75
pubmed: 9529358
Sci Rep. 2017 Sep 11;7(1):11207
pubmed: 28894120
Aging Cell. 2013 Jun;12(3):388-97
pubmed: 23438186
Oncogene. 2006 Aug 7;25(34):4663-74
pubmed: 16892080
Hum Genet. 2014 Sep;133(9):1149-59
pubmed: 24902542
Shock. 2016 Jun;45(6):607-12
pubmed: 26717107
Urol Oncol. 2012 Jul-Aug;30(4):509-15
pubmed: 20870429
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
Pathol Oncol Res. 2017 Jul;23(3):699-706
pubmed: 28035516
Int J Cancer. 2017 Apr 15;140(8):1888-1898
pubmed: 27943272
Obstet Gynecol. 2008 Oct;112(4):843-50
pubmed: 18827127
Mol Oncol. 2014 Jul;8(5):927-41
pubmed: 24698732
Cancer Res. 2007 Oct 1;67(19):9364-70
pubmed: 17909045
Clin Colorectal Cancer. 2015 Mar;14(1):31-4
pubmed: 25446053
J Card Fail. 2016 Oct;22(10):823-8
pubmed: 27349571
Mech Ageing Dev. 2011 Jan-Feb;132(1-2):20-6
pubmed: 21078336
Intern Med. 2014;53(24):2763-71
pubmed: 25500436
PLoS One. 2016 Nov 10;11(11):e0166354
pubmed: 27832189
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2904-9
pubmed: 9409274
Arch Gynecol Obstet. 2007 Oct;276(4):327-31
pubmed: 17431649
Ann Hematol. 2007 Feb;86(2):139-43
pubmed: 17024502
BMC Cancer. 2009 Dec 21;9:454
pubmed: 20025731
Diabetes Res Clin Pract. 2015 Dec;110(3):257-65
pubmed: 26625720
Cancer Res. 1977 Mar;37(3):646-50
pubmed: 837366
Mol Cancer. 2009 Nov 17;8:105
pubmed: 19922604
Ann Oncol. 2009 Aug;20(8):1408-13
pubmed: 19465421
Clin Biochem. 2016 Dec;49(18):1354-1360
pubmed: 27129799
Nutr Rev. 2007 Dec;65(12 Pt 2):S173-6
pubmed: 18240544
NPJ Genom Med. 2018 Nov 23;3:31
pubmed: 30479833
Clin Chem. 2003 Aug;49(8):1286-91
pubmed: 12881444
Sci Signal. 2010 Nov 23;3(149):ra84
pubmed: 21098728
Asian Pac J Cancer Prev. 2015;16(18):8299-305
pubmed: 26745076
Clin Chem. 2003 May;49(5):719-26
pubmed: 12709361
J Gerontol A Biol Sci Med Sci. 2009 May;64(5):581-9
pubmed: 19228783
PLoS One. 2014 Dec 22;9(12):e115433
pubmed: 25532126
Br J Cancer. 2014 Oct 14;111(8):1482-9
pubmed: 25157833
PLoS One. 2012;7(6):e38559
pubmed: 22701665
C R Seances Soc Biol Fil. 1948 Feb;142(3-4):241-3
pubmed: 18875018
Clin Colorectal Cancer. 2013 Sep;12(3):163-7
pubmed: 23871161
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5618-23
pubmed: 15800038
Eur J Cancer Clin Oncol. 1987 Jun;23(6):707-12
pubmed: 3653190
Oncotarget. 2017 Sep 21;8(49):86253-86263
pubmed: 29156792
Ann Surg Treat Res. 2014 Mar;86(3):136-42
pubmed: 24761422
BJU Int. 2008 Aug 5;102(5):628-32
pubmed: 18410441
Clin Cancer Res. 2017 May 15;23(10):2471-2477
pubmed: 27827317
Lancet. 1997 Aug 16;350(9076):485-7
pubmed: 9274585
Cell Mol Life Sci. 2017 Jul;74(14):2689-2707
pubmed: 28315952
Clin Chim Acta. 2013 Sep 23;424:222-30
pubmed: 23727028
Clin Chim Acta. 2001 Nov;313(1-2):139-42
pubmed: 11694251
J Clin Oncol. 2004 Oct 15;22(20):4157-64
pubmed: 15483026
Anal Bioanal Chem. 2017 Apr;409(10):2727-2735
pubmed: 28154880
Cell Mol Life Sci. 2016 Dec;73(23):4355-4381
pubmed: 27652382
Circulation. 1999 Aug 17;100(7):723-8
pubmed: 10449694
Ann Oncol. 2017 Sep 1;28(9):2149-2159
pubmed: 28911069
Int J Cancer. 2013 Sep 1;133(5):1259-65
pubmed: 23404247
Life Sci. 2011 Jul 18;89(3-4):65-71
pubmed: 21683715
Nat Med. 2014 Apr;20(4):430-5
pubmed: 24658074
Cancer Metastasis Rev. 2016 Sep;35(3):347-76
pubmed: 27392603

Auteurs

Romain Meddeb (R)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Zahra Al Amir Dache (ZAA)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Simon Thezenas (S)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.
Biometry Unit, Regional Institute of Cancer of Montpellier, Montpellier, France.

Amaëlle Otandault (A)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Rita Tanos (R)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Brice Pastor (B)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Cynthia Sanchez (C)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Joelle Azzi (J)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Geoffroy Tousch (G)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Simon Azan (S)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Caroline Mollevi (C)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.
Biometry Unit, Regional Institute of Cancer of Montpellier, Montpellier, France.

Antoine Adenis (A)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.
Digestive Oncology Department, Regional Institute of Cancer of Montpellier, Montpellier, France.

Safia El Messaoudi (S)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Philippe Blache (P)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France.
INSERM, U1194, Montpellier, France.
University of Montpellier, Montpellier, France.
Regional Institute of Cancer of Montpellier, Montpellier, France.

Alain R Thierry (AR)

IRCM, Institute of Research in Oncology of Montpellier, Montpellier, France. alain.thierry@inserm.fr.
INSERM, U1194, Montpellier, France. alain.thierry@inserm.fr.
University of Montpellier, Montpellier, France. alain.thierry@inserm.fr.
Regional Institute of Cancer of Montpellier, Montpellier, France. alain.thierry@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH